Colony Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-442,619
| Closed | -$120K | – | 901 |
|
|
2022
Q3 | $120K | Buy |
442,619
+112,332
| +34% | +$49K | ﹤0.01% | 749 |
|
|
2022
Q2 | $254K | Buy |
330,287
+93,952
| +40% | +$83.8K | ﹤0.01% | 726 |
|
|
2022
Q1 | $253K | Buy |
236,335
+95,946
| +68% | +$174K | ﹤0.01% | 762 |
|
|
2021
Q4 | $267K | Sell |
140,389
-7,669
| -5% | -$18.4K | ﹤0.01% | 723 |
|
|
2021
Q3 | $446K | Sell |
148,058
-26,850
| -15% | -$95.6K | 0.01% | 594 |
|
|
2021
Q2 | $684K | Buy |
174,908
+55,860
| +47% | +$232K | 0.01% | 461 |
|
|
2021
Q1 | $604K | Buy |
119,048
+2,456
| +2% | +$12.7K | 0.01% | 493 |
|
|
2020
Q4 | $477K | Sell |
116,592
-5,154
| -4% | -$25.3K | 0.01% | 515 |
|
|
2020
Q3 | $592K | Sell |
121,746
-3,128
| -3% | -$17.1K | 0.02% | 453 |
|
|
2020
Q2 | $692K | Sell |
124,874
-6,652
| -5% | -$30.5K | 0.02% | 402 |
|
|
2020
Q1 | $431K | Sell |
131,526
-1,418
| -1% | -$7.47K | 0.01% | 484 |
|
|
2019
Q4 | $601K | Sell |
132,944
-20,524
| -13% | -$64.9K | 0.02% | 492 |
|
|
2019
Q3 | $638K | Sell |
153,468
-7,507
| -5% | -$27.1K | 0.02% | 443 |
|
|
2019
Q2 | $610K | Buy |
+160,975
| New | +$660K | 0.02% | 471 |
|
Colony Group's AGTC Position: Q4 2022 in Review
Colony Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 442,619 shares — an estimated $120K sold.
Colony Group first reported a position in AGTC in Q2 2019 and held it in 14 quarters. The position peaked at $692K in Q2 2020. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Colony Group reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Colony Group sold 442,619 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $120K.
- Colony Group first reported a position in Applied Genetic Technologies Corporation in Q2 2019 and held it in 14 quarters.
- Colony Group's Applied Genetic Technologies Corporation position peaked at $692K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Colony Group's 13F filing for Q4 2022, filed 14 Feb 2023.